MyFinsight
Home
About
Contact
coll: the income statement
Download
Download image
Symproic
$4,025K
Nucynta Er
$22,813K
Nucynta Ir
$31,988K
Jornay Pm
$41,802K
Xtampza
$50,478K
Belbuca
$58,255K
Product revenues, net
$209,361K
(31.42%↑ Y/Y)
Gross profit
$129,171K
(33.45%↑ Y/Y)
Total cost of product
revenues
$80,190K
(28.29%↑ Y/Y)
Interest income
$3,116K
Income from operations
$62,087K
(78.21%↑ Y/Y)
Total operating
expenses
$67,084K
(8.28%↑ Y/Y)
Gain on fair value
remeasurement of contingent...
-$19K
Intangible asset
amortization and impairment
$55,473K
(35.96%↑ Y/Y)
Cost of product
revenues (excluding...
$24,717K
(13.87%↑ Y/Y)
Income before income
taxes
$43,436K
(178.79%↑ Y/Y)
Interest expense
$21,767K
(18.34%↑ Y/Y)
Selling, general and
administrative
$67,103K
(8.31%↑ Y/Y)
Net income
$31,507K
(237.51%↑ Y/Y)
Provision for income taxes
$11,929K
(91.02%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)